FCS Cancer 360-Plus Magazine: Sparing Breast Cancer Patients From Chemotherapy
By The CCM Team

The study is good news for the nearly 260,000 women in the United States expected to be diagnosed with the disease this year.
Learn more about the TAILORx study and other strategic storytelling from Florida Cancer Specialists, the nation’s largest independent oncology/hematology practice, in our current edition of FCS Cancer 360-Plus magazine.